141 related articles for article (PubMed ID: 33208342)
1. Cobomarsen, an Oligonucleotide Inhibitor of miR-155, Slows DLBCL Tumor Cell Growth
Anastasiadou E; Seto AG; Beatty X; Hermreck M; Gilles ME; Stroopinsky D; Pinter-Brown LC; Pestano L; Marchese C; Avigan D; Trivedi P; Escolar DM; Jackson AL; Slack FJ
Clin Cancer Res; 2021 Feb; 27(4):1139-1149. PubMed ID: 33208342
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated IκBα predicts poor prognosis in activated B-cell lymphoma and its inhibition with thymoquinone induces apoptosis via ROS release.
Hussain AR; Uddin S; Ahmed M; Al-Dayel F; Bavi PP; Al-Kuraya KS
PLoS One; 2013; 8(3):e60540. PubMed ID: 23555990
[TBL] [Abstract][Full Text] [Related]
3. Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044.
Cheng C; Wang T; Song Z; Peng L; Gao M; Hermine O; Rousseaux S; Khochbin S; Mi JQ; Wang J
Cancer Med; 2018 Feb; 7(2):380-396. PubMed ID: 29277967
[TBL] [Abstract][Full Text] [Related]
4. Accumulation of miR-155 and BIC RNA in human B cell lymphomas.
Eis PS; Tam W; Sun L; Chadburn A; Li Z; Gomez MF; Lund E; Dahlberg JE
Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3627-32. PubMed ID: 15738415
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of MALT1 and BCL2 induces synergistic anti-tumor activity in models of B cell lymphoma.
Plotnik JP; Richardson AE; Yang H; Rojas E; Bontcheva V; Dowell C; Parsons S; Wilson A; Ravanmehr V; Will C; Jung P; Zhu H; Partha SK; Panchal SC; Mali RS; Kohlhapp FJ; McClure RA; Ramathal CY; George MD; Jhala M; Elsen NL; Qiu W; Judge RA; Pan C; Mastracchio A; Henderson J; Meulbroek JA; Green MR; Pappano WN
Mol Cancer Ther; 2024 Mar; ():. PubMed ID: 38507740
[TBL] [Abstract][Full Text] [Related]
6. Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Le Gouill S; Ghesquières H; Oberic L; Morschhauser F; Tilly H; Ribrag V; Lamy T; Thieblemont C; Maisonneuve H; Gressin R; Bouhabdallah K; Haioun C; Damaj G; Fornecker L; Bouhabdallah R; Feugier P; Sibon D; Cartron G; Bonnet C; André M; Chartier L; Ruminy P; Kraeber-Bodéré F; Bodet-Milin C; Berriolo-Riedinger A; Brière J; Jais JP; Molina TJ; Itti E; Casasnovas RO
Blood; 2021 Apr; 137(17):2307-2320. PubMed ID: 33211799
[TBL] [Abstract][Full Text] [Related]
7. Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphoma.
Razzaghi R; Agarwal S; Kotlov N; Plotnikova O; Nomie K; Huang DW; Wright GW; Smith GA; Li M; Takata K; Yamadi M; Yao C; O'Shea JJ; Phelan JD; Pittaluga S; Scott DW; Muppidi JR
J Exp Med; 2021 Mar; 218(3):. PubMed ID: 33237303
[TBL] [Abstract][Full Text] [Related]
8. Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma.
Hamadani M; Radford J; Carlo-Stella C; Caimi PF; Reid E; O'Connor OA; Feingold JM; Ardeshna KM; Townsend W; Solh M; Heffner LT; Ungar D; Wang L; Boni J; Havenith K; Qin Y; Kahl BS
Blood; 2021 May; 137(19):2634-2645. PubMed ID: 33211842
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a Selective, Covalent IRAK1 Inhibitor with Antiproliferative Activity in MYD88 Mutated B-Cell Lymphoma.
Hatcher JM; Yang G; Wang L; Ficarro SB; Buhrlage S; Wu H; Marto JA; Treon SP; Gray NS
ACS Med Chem Lett; 2020 Nov; 11(11):2238-2243. PubMed ID: 33214835
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Na Y; Hall A; Choi K; Hu L; Rose J; Coover RA; Miller A; Hennigan RF; Dombi E; Kim MO; Subramanian S; Ratner N; Wu J
Oncogene; 2021 Feb; 40(5):951-963. PubMed ID: 33293695
[TBL] [Abstract][Full Text] [Related]
11. [Effect of bone marrow mononuclear cell transplantation on miRNA-21 and miRNA-155 expression in mice with ulcerative colitis].
Yang S; Jiang W; Bao XQ; Yao W; Chen G; Zhang H; Chen X; Bu Q; Yang SH; Qi YN; Wang WQ; Han YP
Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(44):3529-3533. PubMed ID: 33256297
[No Abstract] [Full Text] [Related]
12. Identification BCL6 and miR-30 family associating with Ibrutinib resistance in activated B-cell-like diffuse large B-cell lymphoma.
Li J; Huang Y; Zhang Y; Wen J; Chen Y; Wang L; Jiang P; Hu J
Med Oncol; 2021 Feb; 38(4):33. PubMed ID: 33629212
[TBL] [Abstract][Full Text] [Related]
13. Targeted eicosanoids profiling reveals a prostaglandin reprogramming in breast Cancer by microRNA-155.
Kim S; Lee ES; Lee EJ; Jung JY; Lee SB; Lee HJ; Kim J; Kim HJ; Lee JW; Son BH; Gong G; Ahn SH; Chang S
J Exp Clin Cancer Res; 2021 Jan; 40(1):43. PubMed ID: 33494773
[TBL] [Abstract][Full Text] [Related]
14. CREBBP/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2/CSF1 axis.
Huang YH; Cai K; Xu PP; Wang L; Huang CX; Fang Y; Cheng S; Sun XJ; Liu F; Huang JY; Ji MM; Zhao WL
Signal Transduct Target Ther; 2021 Jan; 6(1):10. PubMed ID: 33431788
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies.
Kim T; Croce CM
Exp Mol Med; 2023 Jul; 55(7):1314-1321. PubMed ID: 37430087
[TBL] [Abstract][Full Text] [Related]
16. miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer.
Miliotis C; Slack FJ
Cancer Lett; 2021 Oct; 518():115-126. PubMed ID: 34098061
[TBL] [Abstract][Full Text] [Related]
17. The RAS oncogene in brain tumors and the involvement of let-7 microRNA.
Messina S
Mol Biol Rep; 2024 Apr; 51(1):531. PubMed ID: 38637419
[TBL] [Abstract][Full Text] [Related]
18. Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review.
Nappi F
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612441
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs: Potential prognostic and theranostic biomarkers in chronic lymphocytic leukemia.
Ali A; Mahla SB; Reza V; Hossein A; Bahareh K; Mohammad H; Fatemeh S; Mostafa AB; Leili R
EJHaem; 2024 Feb; 5(1):191-205. PubMed ID: 38406506
[TBL] [Abstract][Full Text] [Related]
20. Trials and Tribulations of MicroRNA Therapeutics.
Seyhan AA
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
